USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Attention Deficit Hyperactivity Disorder (ADHD) Markets
U.S. Attention Deficit Hyperactivity Disorder (ADHD) Markets
RELEASE DATE
30-May-2003
30-May-2003
REGION
North America
North America
Research Code: A450-01-00-00-00
SKU: HC00885-NA-MR_04656
$2,450.00
In stock
SKU
HC00885-NA-MR_04656
Description
The U.S. Attention Deficit Hyperactivity Disorder markets report provides revenue forecasts, patient forecasts, competitive analysis, market trends, and product analysis. The market is segmented by product class, namely the stimulant therapies market and the non-stimulant therapies market. Within these segments, emphasis is placed on evaluation of the once and twice-thrice daily products in the stimulant therapies market segment and Strattera and other emerging products in the non-stimulant therapies market segment. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
Table of Contents
Executive Summary
- Executive Summary
ADHD Overview
- Introduction
- Report Scope and Segmentation
- Customer Segmentation and Targeting Strategies
- Diagnostic Developments Shaping the ADHD Prescription Market
Macroeconomic Analysis
- Political and Regulatory Trends
- Social Dynamics and Trends
- Economic and Reimbursement Trends and Impact
- Technological Trends and Strategies
Market Forecasts and Trends
- Demand Analysis (Children Adolescents and Adults)
- Pricing Trends
- Revenue Forecast
- Market Engineering Analysis
Competitive Analysis
- Competitive Scenario and Industry Attractiveness
- Selected Competitor Profiles and Strategic Relationships
- Product Life Cycle Analysis
- Growth Strategies
Product Analysis
- Approved Products & Patent and Market Exclusivity Expirations
- Product Pipeline
- Analysis of Unmet Patient Needs and Treatment Trends
Challenges and Strategic Recommendations
- Limited Product Differentiation and Increasing Generic Presence Puts Downward Pressure on Prices
- Subjectivity of Diagnosis Inhibits Demand and Constrains Revenue Potential
- Growing Difficulty in Securing Reimbursement Curbs Revenue Growth
- Concern About Artificially Increasing Demand for Medication Incites Stricter Regulatory Enforcement
Overview
Forecasts and Trends
Overview
Forecasts and Trends
Popular Topics
The U.S. Attention Deficit Hyperactivity Disorder markets report provides revenue forecasts, patient forecasts, competitive analysis, market trends, and product analysis. The market is segmented by product class, namely the stimulant therapies market and the non-stimulant therapies market. Within these segments, emphasis is placed on evaluation of the once and twice-thrice daily products in the stimulant therapies market segment and Strattera and other emerging products in the non-stimulant therapies market segment. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A450-01-00-00-00 |
| Is Prebook | No |